HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characterization and regulation of the expression of scyllatoxin (Leiurotoxin I) receptors in the human neuroblastoma cell line NB-OK 1.

Abstract
125I-[Tyr2]scyllatoxin allowed to label a single class of high-affinity receptors in membranes from the human neuroblastoma cell line NB-OK 1. The Kd of these receptors was 60 pM for scyllatoxin (Leiurotoxin I) and 20 pM for apamin and the Bmax was low (3.8 fmol/mg membrane protein). K+ increased toxin binding at low concentrations but exerted opposite effects at high concentrations. Ca2+, guanidinium and Na+ exerted only inhibitory effects on binding. Scyllatoxin binding sites were overexpressed 2.5-fold after a 24-h cell pretreatment with 2 mM butyrate. This effect was suppressed by cycloheximide.
AuthorsD Gossen, J C Gesquière, M Tastenoy, P De Neef, M Waelbroeck, J Christophe
JournalFEBS letters (FEBS Lett) Vol. 285 Issue 2 Pg. 271-4 (Jul 22 1991) ISSN: 0014-5793 [Print] England
PMID1855593 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Butyrates
  • Guanidines
  • Potassium Channels
  • Receptors, Cholinergic
  • Scorpion Venoms
  • scyllatoxin receptor
  • Butyric Acid
  • leiurotoxin I
  • Apamin
  • Cycloheximide
  • Sodium
  • Guanidine
  • Potassium
  • Calcium
Topics
  • Amino Acid Sequence
  • Apamin (antagonists & inhibitors, metabolism)
  • Butyrates (pharmacology)
  • Butyric Acid
  • Calcium (metabolism)
  • Cell Membrane (metabolism)
  • Cycloheximide (pharmacology)
  • Gene Expression Regulation (drug effects)
  • Guanidine
  • Guanidines (metabolism)
  • Humans
  • Kinetics
  • Molecular Sequence Data
  • Neuroblastoma
  • Potassium (metabolism)
  • Potassium Channels
  • Radioligand Assay
  • Receptors, Cholinergic (drug effects, metabolism)
  • Scorpion Venoms (metabolism)
  • Sodium (metabolism)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: